Journal of Pediatric Epilepsy 2021; 10(03): 121-123
DOI: 10.1055/s-0040-1721731
Case Report

Carbamazepine-Induced Nonepileptic Myoclonus in a Child with Autism and Epilepsy

Serkan Kirik
1   Department of Pediatric Neurology, Firat University School of Medicine, Elazig, Turkey
,
Uluc Yis
2   Department of Pediatric Neurology, Dokuz Eylul University School of Medicine, Konak, Turkey
› Institutsangaben

Funding None.
Preview

Abstract

This study deals with a child with different type of seizures several times in week and unresponsive to antiepileptic drugs. Distinguishing between epileptic seizure and motor tic in a patient diagnosed with epilepsy and autism can be challenging. In this study we presented a male child patient on carbamazepine (CBZ) therapy. In the first days of treatment seizure frequency decreased, but after CBZ treatment dosage reached 15 mg/kg/day (at the 25th day of the treatment), the patient presented to the clinic describing several episodes of myoclonus. There were no changes in electroencephalography during the myoclonus. In follow-up, myoclonus was not described after the cessation of CBZ.



Publikationsverlauf

Eingereicht: 17. September 2020

Angenommen: 03. November 2020

Artikel online veröffentlicht:
20. Januar 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany